These markets typically experience higher economic
growth than developed countries and are characterized by industrialization and a growing middle class.
Not exact matches
«We have lots of opportunities in these
countries where we can get better
growth than we can in
developed countries,» he says.
In the months following its international launch, Netflix's subscriber
growth was weaker
than many analysts expected, and many argued that this was partly because broadband Internet access is not as widespread in many
developing countries.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain
growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European
countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger
than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to
develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully
develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Minister in the Prime Minister's Department Datuk Seri Abdul Rahman Dahlan said the
country's GDP
growth has overtaken Singapore, Indonesia and even higher
than certain
developed countries like the United States.
Many of the
developing Asian
countries have higher food output
growth per year
than Australia.
Armed with 200 years of taxation receipts and other economic indices from
developed countries (mainly France, Britain and the US) he shows there is one economic law that approaches a constant: the rate of return on capital (r) is usually higher
than the rate of economic
growth (g).
However, for the period 2010 - 2012, more
than half of China's export emissions resulted from the
growth in foreign trade to
developing countries.
The percentage of those living on less
than $ 1.25 a day in
developing countries fell from 43 % in 1990 to 17 % in 2011, driven largely by economic
growth in China and India.
China is the third largest producer of these services (17 percent global share) and continues to grow at a far faster rate (19 percent annual
growth)
than the U.S. and other
developed countries.
While the average rate of
growth has decreased steadily since the 1970s, Moses says the 18 percent of its gross domestic product (GDP) that the United States spends on health care is 50 to 60 percent higher
than any other
developed country.
In fact, their economies have grown more quickly
than they have issued debt, leading to a substantial drop in their debt - to - GDP ratios.7 Although their budget deficits remain higher
than that of the average
developed country, they are now well below their rate of GDP
growth (something many
developed market
countries can't claim).
We see this environment as positive for equities in the US and other
developed countries as stronger
growth will more
than offset higher interest rates.
And nearly all of the projected
growth rates in emissions of carbon dioxide (and five other kinds of heat - trapping gases included in the determination) in the next few decades are expected to occur in fast - growing
developing countries, led by China and India (which by midcentury is expected to be have more people
than China and even today has the population density of Japan).
While the United States and Europe are responsible for the vast majority of the carbon dioxide added to the atmosphere through the industrial era, the International Energy Agency foresees more
than 90 percent of the
growth in such emissions coming from
developing countries, led by China.
Given that Americans, per person, produce many times more carbon dioxide emissions
than people in
developing countries (at least for a few more decades), the
growth in the United States has added significance for climate projections, said Leiwen Jiang, senior demographer at Population Action International, a nonprofit research group.
But Mr. Revkin, I actually think this question is off — it is impossible to really answer it without getting into the debate, which comes up a lot on DotEarth as elsewhere, about what right we have to dictate to
developing countries that they pursue more expensive
growth strategies
than we ourselves did.
India has argued that
developing countries should not be asked to take steps to curtail their
growth when they contribute less pollution per person
than developed countries.
Its key claim is that, unless the climate regime explicitly preserves such a right,
developing country negotiators may quite justifiably conclude [iii] that they have more to lose
than to gain from any truly earnest engagement with a global climate regime that, after all, significantly curtails access to the energy sources and technologies that historically enabled
growth in the industrialized world.
The use of coal as a fuel has now surpassed oil and
developing countries now emit more greenhouse gases
than developed countries — with a quarter of their
growth in emissions accounted for by increased trade with the West.
When mitigating anthropogenic global warming is projected to require greater
than 80 % lower fossil energy use, how do we provide the transport fuel and energy for rapid
growth by
developing countries while sustaining OECD economic
growth when the Available Net Exports of crude oil — after China and India's imports — have already declined 13 % since 2005, and Saudi Arabia may need to import oil by 2030?
Economic
growth in
developing countries was much more important
than countering global warming, Mr Howard said, and the West had no right to deny economic development to the rest of the world in the name of climate change.
Stern stressed that if
developed countries can show examples where they have achieved low - carbon
growth, it would be far more powerful
than just talking about it.
The use of coal as a fuel has now surpassed oil and
developing countries now emit more greenhouse gases
than developed countries â $ «with a quarter of their
growth in emissions accounted for by increased trade with the West.
The demand for financial resources to finance solutions is huge - $ 2,100 billion for power generation in
developing countries alone in the next 30 years, and that to do little more
than keep pace with population
growth, leaving far too many still without electricity.
And it's not entirely a problem of population
growth in the
developing world — though that is a part of the equation — the eco-footprint of one person in the United States, France or Canada is much greater
than a person in India, Brazil or any number of African
countries.
The
growth is being fueled primarily by
developing countries, especially China and India, where economies are fast - expanding and population continues to increase at a significantly higher rate
than in industrialized nations.
Currently, transport's share of GHG emissions is signficantly lower in
developing countries than it is in OECD
countries, notably the U.S.. However, emission
growth is heading north.
• A higher rate of
growth in the US's UHNWI population is expected in the next 10 years
than for many other
developed countries, despite uncertainties surrounding Trump's policies.